These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26758977)

  • 41. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRAK interacts with DJ-1 and prevents oxidative stress-induced cell death.
    Tang J; Liu J; Li X; Zhong Y; Zhong T; Liu Y; Wang JH; Jiang Y
    Oxid Med Cell Longev; 2014; 2014():735618. PubMed ID: 25383140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of PRAK subcellular location by p38 MAP kinases.
    New L; Jiang Y; Han J
    Mol Biol Cell; 2003 Jun; 14(6):2603-16. PubMed ID: 12808055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.
    Origlia N; Bonadonna C; Rosellini A; Leznik E; Arancio O; Yan SS; Domenici L
    J Neurosci; 2010 Aug; 30(34):11414-25. PubMed ID: 20739563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction.
    Takuma K; Fang F; Zhang W; Yan S; Fukuzaki E; Du H; Sosunov A; McKhann G; Funatsu Y; Nakamichi N; Nagai T; Mizoguchi H; Ibi D; Hori O; Ogawa S; Stern DM; Yamada K; Yan SS
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20021-6. PubMed ID: 19901339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
    Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
    J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting.
    Paudel YN; Angelopoulou E; Piperi C; Othman I; Aamir K; Shaikh MF
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.
    Kojro E; Postina R
    J Alzheimers Dis; 2009; 16(4):865-78. PubMed ID: 19387119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model.
    Guo C; Zhang S; Li JY; Ding C; Yang ZH; Chai R; Wang X; Wang ZY
    Sci Rep; 2016 Jul; 6():29396. PubMed ID: 27406855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.
    Walker D; Lue LF; Paul G; Patel A; Sabbagh MN
    Expert Opin Investig Drugs; 2015 Mar; 24(3):393-9. PubMed ID: 25586103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D-ribose and pathogenesis of Alzheimer's disease.
    Javed M; Ahmad MI; Javed H; Naseem S
    Mol Biol Rep; 2020 Mar; 47(3):2289-2299. PubMed ID: 31933261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
    Wan W; Chen H; Li Y
    Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of low density lipoprotein receptor-related protein 6 is involved in receptor for advanced glycation end product-mediated β-catenin stabilization in a toluene diisocyanate-induced asthma model.
    Xiong J; Zhao W; Lin Y; Yao L; Huang G; Yu C; Dong H; Xiao G; Zhao H; Cai S
    Int Immunopharmacol; 2018 Jun; 59():187-196. PubMed ID: 29656209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats.
    Ma LY; Fei YL; Wang XY; Wu SD; Du JH; Zhu M; Jin L; Li M; Li HL; Zhai JJ; Ji LP; Ma RR; Liu SF; Li M; Ma L; Ma XR; Qu QM; Lv YL
    J Mol Neurosci; 2017 May; 62(1):1-10. PubMed ID: 28401370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease.
    Du Yan S; Zhu H; Fu J; Yan SF; Roher A; Tourtellotte WW; Rajavashisth T; Chen X; Godman GC; Stern D; Schmidt AM
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5296-301. PubMed ID: 9144231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.